Incidence and Risk Factors for De Novo Cutaneous Squamous Cell Carcinoma in a Contemporary Cohort of Long-Term Hematopoietic Cell Transplantation Survivors.
作者信息
Berano Teh Jennifer, Abdulla Farah, Peng Kelly, Atencio Liezl, Echevarria Meagan, Iukuridze Aleksi, Geller Alan C, Wong F Lennie, Forman Stephen J, Nakamura Ryotaro, Modi Badri, Armenian Saro H
机构信息
Department of Population Sciences, City of Hope, Duarte, California, USA.
Division of Dermatology, Department of Surgery, City of Hope, Duarte, California, USA.
出版信息
J Invest Dermatol. 2021 Aug;141(8):2073-2076.e5. doi: 10.1016/j.jid.2021.01.018. Epub 2021 Feb 18.
Abstract
摘要
相似文献
1
Incidence and Risk Factors for De Novo Cutaneous Squamous Cell Carcinoma in a Contemporary Cohort of Long-Term Hematopoietic Cell Transplantation Survivors.当代长期造血细胞移植幸存者队列中新生皮肤鳞状细胞癌的发病率及危险因素
J Invest Dermatol. 2021 Aug;141(8):2073-2076.e5. doi: 10.1016/j.jid.2021.01.018. Epub 2021 Feb 18.
2
Voriconazole exposure and the risk of cutaneous squamous cell carcinoma in allogeneic hematopoietic stem cell transplant patients.伏立康唑暴露与异基因造血干细胞移植患者皮肤鳞状细胞癌风险
Transpl Infect Dis. 2015 Apr;17(2):250-8. doi: 10.1111/tid.12367.
3
High-risk cutaneous squamous cell carcinoma in a Japanese allogeneic bone marrow transplant recipient on long-term voriconazole.长期伏立康唑治疗的日本异基因骨髓移植受者的高危皮肤鳞状细胞癌。
J Dermatol. 2017 Oct;44(10):1152-1155. doi: 10.1111/1346-8138.13867. Epub 2017 May 4.
4
High incidence of oral squamous cell carcinoma independent of HPV infection after allogeneic hematopoietic SCT in Taiwan.台湾地区异基因造血干细胞移植后 HPV 感染无关的口腔鳞状细胞癌高发生率。
Bone Marrow Transplant. 2011 Apr;46(4):567-72. doi: 10.1038/bmt.2010.163. Epub 2010 Jul 12.
5
Reduced-Intensity Conditioning Regimens, Prior Chronic Lymphocytic Leukemia, and Graft-Versus-Host Disease Are Associated with Higher Rates of Skin Cancer after Allogeneic Hematopoietic Stem Cell Transplantation.异基因造血干细胞移植后，低强度预处理方案、慢性淋巴细胞白血病既往史和移植物抗宿主病与皮肤癌发生率升高相关。
J Invest Dermatol. 2019 Mar;139(3):591-599. doi: 10.1016/j.jid.2018.08.025. Epub 2018 Oct 11.
6
Morbidity burden in survivors of multiple myeloma who underwent autologous transplantation: A Bone Marrow Transplantation Survivor Study.接受自体移植的多发性骨髓瘤幸存者的疾病负担：一项骨髓移植幸存者研究。
Cancer. 2020 Jul 15;126(14):3322-3329. doi: 10.1002/cncr.32941. Epub 2020 May 15.
7
Chronic graft-versus-host disease with skin signs suspicious for squamous cell carcinoma.伴有皮肤表现且高度怀疑为鳞状细胞癌的慢性移植物抗宿主病。
Acta Oncol. 2013 Aug;52(6):1213-4. doi: 10.3109/0284186X.2012.734923. Epub 2012 Dec 3.
8
Timing and Number of Cutaneous Squamous Cell Carcinomas in Transplant Recipients.移植受者皮肤鳞状细胞癌的发生时间和数量。
JAMA Dermatol. 2018 Jun 1;154(6):727-728. doi: 10.1001/jamadermatol.2018.0856.
9
Cutaneous Malignant Neoplasms in Hematopoietic Cell Transplant Recipients: A Systematic Review.造血干细胞移植受者的皮肤恶性肿瘤：系统评价。
JAMA Dermatol. 2015 Jul;151(7):775-82. doi: 10.1001/jamadermatol.2015.121.
10
Nonmelanoma skin and mucosal cancers after hematopoietic cell transplantation.造血细胞移植后的非黑色素瘤皮肤和黏膜癌
J Clin Oncol. 2006 Mar 1;24(7):1119-26. doi: 10.1200/JCO.2005.02.7052. Epub 2006 Feb 6.
引用本文的文献
1
Incidence of and Risk Factors for Cutaneous Malignant Neoplasms After Blood or Marrow Transplant.血液或骨髓移植后皮肤恶性肿瘤的发病率及危险因素
JAMA Dermatol. 2025 Mar 1;161(3):265-273. doi: 10.1001/jamadermatol.2024.5129.
本文引用的文献
1
Current Use of and Trends in Hematopoietic Cell Transplantation in the United States.美国造血细胞移植的当前使用情况及趋势
Biol Blood Marrow Transplant. 2020 Aug;26(8):e177-e182. doi: 10.1016/j.bbmt.2020.04.013. Epub 2020 May 11.
2
Primary Care Physician Perspectives on Caring for Adult Survivors of Hematologic Malignancies and Hematopoietic Cell Transplantation.初级保健医生对血液系统恶性肿瘤和造血细胞移植成年幸存者护理的看法。
Clin Lymphoma Myeloma Leuk. 2020 Feb;20(2):70-77. doi: 10.1016/j.clml.2019.11.008. Epub 2019 Nov 13.
3
Dermoscopy for melanoma detection and triage in primary care: a systematic review.皮肤科镜检查在初级保健中用于黑色素瘤的检测和分诊：系统评价。
BMJ Open. 2019 Aug 20;9(8):e027529. doi: 10.1136/bmjopen-2018-027529.
4
Ascertainment of Unmet Needs and Participation in Health Maintenance and Screening of Adult Hematopoietic Cell Transplantation Survivors Followed in a Formal Survivorship Program.确定未满足的需求以及参与正式生存项目中成年造血细胞移植存活者的健康维持和筛查。
Biol Blood Marrow Transplant. 2017 Nov;23(11):1968-1973. doi: 10.1016/j.bbmt.2017.07.024. Epub 2017 Aug 4.
5
Effect of voriconazole on risk of nonmelanoma skin cancer after hematopoietic cell transplantation.伏立康唑对造血细胞移植后非黑色素瘤皮肤癌风险的影响。
J Am Acad Dermatol. 2017 Oct;77(4):706-712. doi: 10.1016/j.jaad.2017.06.032. Epub 2017 Aug 2.
6
Risk of Second Malignancies in Solid Organ Transplant Recipients Who Develop Keratinocyte Cancers.发生角质形成细胞癌的实体器官移植受者发生第二原发性恶性肿瘤的风险
Cancer Res. 2017 Aug 1;77(15):4196-4203. doi: 10.1158/0008-5472.CAN-16-3291. Epub 2017 Jun 14.
7
The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin.辅助性 T 细胞 17 通路与肠道、肺部和皮肤的炎症性疾病。
Annu Rev Pathol. 2013 Jan 24;8:477-512. doi: 10.1146/annurev-pathol-011110-130318. Epub 2012 Nov 15.
8
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): explanation and elaboration.流行病学观察性研究报告的强化（STROBE）：解释与详述
PLoS Med. 2007 Oct 16;4(10):e297. doi: 10.1371/journal.pmed.0040297.
Zotero 插件